Top 50 Medical Startup Investors in China in January 2026

Investor	Medical China investments
BioVenture	34
HSG	34
Qiming Venture Partners	29
Med-Fine Capital	25
Legend Capital	23
Frees Fund	20
Cowin Venture	18
Lilly Asia Ventures	17
Shanghai Biomedical Industrial Equity Investment Fund	17
Puhua Capital	17
Marathon Venture Partners	17
IDG Capital	16
Prox Ventures	16
Matrix Partners China	16
ZSVC	15
Northern Light Venture Capital	15
Legend Star	15
Share Capital	15
Jan Hammer	14
Cowin Capital	14
CDH Investments	13
Dalton Venture	13
Highlight Capital	13
Goldport Capital	12
Sherpa Healthcare Partners	12
BioTrack Capital	12
Taiyu Investment	11
Lenovo Capital and Incubator Group (LCIG)	11
Cenova	10
Shenzhen Capital Group	10
Long Hill Capital	10
Sunland Fund	9
Hillhouse Investment	9
Gaorong Capital	9
CD Capital	9
Trustbridge Partners	9
Kaitai Capital	9
Huagai Capital	9
Oriza Seed Capital (Oriza Yuandian)	9
Shunwei Capital	8
Sunz Fund	8
Haibang Capital	8
Taiyu Investment	8
TaiKun Fund	8
Longpan Investment	8
Pan-Lin Capital	8
Oriental Fortune Capital	8
Insight Capital	8
Co-Stone Venture Capital	8
SBCVC	8

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Hong Kong

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Artificial Intelligence
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Keystone — Kesytone is a hardware wallet for bitcoin, Ethereum, USDT, BCH, and cryptocurrencies.
Ronghe Medical — Ronghe Medical is a medical device manufacturer specializing in the design, research and development, production, and sales of high-end medical device systems based on advanced energy ablation technology platforms, delivering innovative therapeutic solutions that enhance clinical precision, improve patient outcomes, and support a wide range ofmedical applications.
InfStones — Founded in 2018 with offices across three countries and two continents, InfStones is the world's leading blockchain infrastructure provider. Currently, InfStones provides services to large institutional clients around the globe, supporting thousands of nodes on more than 50 public blockchains through its universal platform.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Obita — Obita is a B2B financial network that offers stablecoin-driven transactions for enterprises, merchants, and fintechs.
X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Medical, Biotechnology
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

Baiyao Technology — Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes.
Boin Biotechnology — Boin Biotechnology is a cutting-edge biopharmaceutical company. The company is dedicated to the development of gene therapy drugs, with a particular focus on advancing the next generation of gene therapy.
Dingou Biopharmaceuticals — Dingou Biotechnology is a developer of allergen diagnosis and treatment products, mainly engaged in allergen-specific diagnosis and treatment business

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Investment focus

Health Care, Biotechnology, Medical
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.
Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Enchannel — Enchannel Medical is a global innovation platform that focuses on electrophysiology and provides atrial fibrillation treatment solution around "3D mapping + PFA ablation".
Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Hong Kong

Portfolio highlights

Editact — Editact specializes in the development of novel gene treatments for Alzheimer's disease. It focuses on unmet clinical requirements in familial Alzheimer's disease (FAD) and is developing "one-to-many" gene editing therapeutics.
Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
NeuShen Therapeutics — NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Manufacturing
Series A, Series B, Seed
China, United Kingdom, United States

Portfolio highlights

Anten — Anten is a high-tech enterprise dedicated to the research, development, and production of innovative dietary supplements and precision nutrition technologies, aiming to promote personalized health and wellness solutions through scientifically backed formulations and cutting-edge biotechnological advancements.
Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
Kangai Medical — Kangai Medical specialises on clinical nutrition and rehabilitation
Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Kaiwuji — Kaiwuji is an emerging company in the AI4Materials field.
Hongxin Biology — Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Rongguang Optics — Rongguang Optics is a company specializing in optical instrument manufacturing, along with vacuum coating processing, industrial design services, and plastic product manufacturing.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Seed, Funding Round, Series A
China, United States, United Kingdom

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Levostar — Levostar Biotech_Innovative Solutions for Innovative Therapies Levostar Biotech is a technology-driven enterprise focused on innovative technologies for Advanced Therapy Medicinal Products.
RoboParty — RoboParty is a bipedal robot technology company that specializes in research, development, and engineering of humanoid robots.
Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Investment focus

Manufacturing, Medical, Health Care
Series A, Seed, Series B
China, United States, India

Portfolio highlights

Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
Deruicore — Deruicore is an integrated research and development based manufacturing company.
Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
Hertz Life Science Technology — Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Angel
China, United States, France

Portfolio highlights

VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
Zhizai Wujie — Zhizai Wujie is a robotics company that specializes in research, development, and application of humanoid robots.
Direct Drive Technology — Direct Drive Technology provides direct drive solutions to replace the reduction gears in any machine. The company has a complete set of technologies for robot joints from sensors, drivers to motor bodies. Drive Tech uses a unique direct drive precise & powerful motion solution, thereby helping many other industries to boost different products.

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Colombia

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.

Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, Czech Republic

Portfolio highlights

Sofía — Improving the way millions of people take care of their health
Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Seed
China, Hong Kong, United States

Portfolio highlights

Yiqi Future — Yiqi Future is a cutting-edge high-tech company dedicated to the research, development, and innovation of advanced AI-powered physical therapy robots. With a strong focus on integrating artificial intelligence, robotics, and biomedical engineering, the company aims to revolutionize the rehabilitation and healthcare industry by providingintelligent, efficient, and personalized therapeutic solutions.
Zhongzhi Xinying — Zhongzhi Xinying is a laser processing solution provider focused on developing and applying laser technology. Its products serve industries such as aerospace, rail transportation, shipbuilding, IT manufacturing, and medical.
Pengnao Technology — Pengnao Technology is an innovative brain-computer interface company with independent intellectual property rights, dedicated to advancing neural interaction technologies that bridge the gap between the human brain and intelligent systems.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

TMiRob — TMiRob is a medical robot developer that works with hospitals and clinics to develop medical robots to improve the work efficiency of medical workers. The medical robots developed by TMiRob can be used in medical treatment assistance and nursing services in hospitals and clinics.
SenseTime — SenseTime is a leading AI software company focused on creating a better AI-empowered future through innovation. Upholding a vision of advancing the interconnection of physical and digital worlds with AI, driving sustainable productivity growth and seamless interactive experiences, SenseTime is committed to advancing AI research, developing scalableand affordable AI software platforms that benefit businesses, people, and society, as well as attract and nurture top talents to shape the future together.With their roots in the academic world, we invest in original and cutting-edge research that allows them to offer and continuously improve industry-leading, full-stack AI capabilities, covering key fields across perception intelligence, decision intelligence, AI-enabled content generation, and AI-enabled content enhancement, as well as key capabilities in AI chips, sensors and computing infrastructure. Their proprietary AI infrastructure, SenseCore, allows us to develop powerful and efficient AI software platforms that are scalable and adaptable for a wide range of applications. Their technologies are trusted by customers and partners in many industry verticals including Smart Business, Smart City, Smart Life, and Smart Auto.SenseTime has been actively involved in the development of national and international industry standards on data security, privacy protection, ethical and sustainable AI. As of June 30, 2021, SenseTime has participated in the formulation of over 80 national or international industry standards, working closely with multiple domestic and multilateral institutions on ethical and sustainable AI development. SenseTime was the only AI company in Asia to have its Code of Ethics for AI Sustainable Development selected by the United Nations as one of the key publication references in the United Nations Resource Guide on AI Strategies published in June 2021.They have offices in markets including Hong Kong, Mainland China, Macau, Taiwan, Japan, Malaysia, Singapore, South Korea, Saudi Arabia, and the United Arab Emirates, among others, as well as a presence in Thailand, Indonesia, and the Philippines.
Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Seed, Series A, Series B
India, China, Canada

Portfolio highlights

Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
E-nitiate Biopharmaceuticals — E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.

Goldport Capital is a Shenzhen-based asset management company.

Investment focus

Manufacturing, Medical, Semiconductor
Series A, Seed, Angel
China

Portfolio highlights

Yurucheng — Yurucheng is a brand of oral materials, specializing in the R&D, production, sales and service of medical oral materials and oral equipment.
Zinc Core Titanium — Zinc Core Titanium makes special materials that light up and tiny screens for displays.
Rongxin New Materials — Rongxin New Materials is a developer specializing in graphene material science and technology, with a commitment to the research and development of new materials technology and engineering applications. The company focuses on graphene-based heating films and graphene-integrated thermal products that are designed to provide efficient and uniformheating solutions for both consumer and industrial sectors.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
PAQ Therapeutics — PAQ Therapeutics is developing KRAS degraders for deadly cancers without good treatment options.
Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Spurious — Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies.
Cavan Auto — Cavan Auto specializes in the production of electric vehicles and hydrogen fuel cell-powered new energy.
Minghui Pharmaceutical — Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Taiyu Investment is an investment firm.

Investment focus

Medical, Medical Device, Biotechnology
Series A, Angel, Seed
China

Portfolio highlights

NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Investment focus

Manufacturing, Artificial Intelligence, Software
Series A, Series B, Seed
China, Hong Kong, United States

Portfolio highlights

DexForce — DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots.
Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
West Lake Yanshan Technology — West Lake Yanshan Technology is a micro-LED company that focuses on the manufacturing and production of full-color display chips.

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, Singapore, United States

Portfolio highlights

Weimai — Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing userswith a family doctor application in every home.
Haofeng Medtech — Haofeng Medtech is a CDMO service provider of interventional medical devices.
Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Investment focus

Manufacturing, Health Care, Information Technology
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Biosun Pharma — Biosun Pharma is an innovative biopharmaceutical company that specializes in the production of drugs for tumors, self-immune diseases, and inflammatory diseases.
Tuowei Tianhai — TWTH committed to minimizing export costs of logistics in China by establishing the most convenient and efficient Sino-US transport brand. It is dedicated to providing Sino-US ocean freight LCL Door-to-Door service, air freight Door-to-Door service, ocean freight FCL Door-to-Door service, international express service, CNRAM and otherinternational freight services.
Yuchuang Semiconductor — Erised Semiconductor is a circuit designer and manufacturer that provides users with display driver and power management chips. The applications can be found in radiofrequency applications, discrete devices, and other products.

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

Investment focus

Medical, Health Care, Medical Device
Series A, Series B, Angel
China, United States

Portfolio highlights

Qingyun Technology — Qingyun Technology is an artificial intelligence digital marketing platform company focusing on the pharmaceutical industry.
Shengnuo Medical — Sono Medical is a biomedical technology company that focuses on R&D, design, production and sales of edical equipment in the field of cardiovascular diseases.
Wangli Technology — Wangli Technology is a digital therapy technology platform for mental illness focusing on exploring the field of human brain and spirit.

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics

Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.

Investment focus

Information Technology, Artificial Intelligence, E-Commerce
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Nova Fusion — Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors.
Cornerstone Robotics — Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.

Investment focus

Health Care, Education, Medical
Series A, Series B, Series C
China, United States, United Kingdom

Portfolio highlights

Cherre — Connect all your real estate data and make it available to the entire organization for better investment, management, and underwriting decisions.
Metafoodx — Metafoodx is on a mission to solve the challenge of food waste. We believe that it is one of the most critical factors for achieving global sustainability.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Angel, Series B
China, United States

Portfolio highlights

OncoC4 — OncoC4 develops first-in-class and best-in-class medicines for hard-to-treat cancers by leveraging CTLA-4, CD24, and siglecs
Primelink Bio — Primelink Bio is a Biotechnology firm that is working to to develop next generation of drug delivery systems.
Sheng Sheng Biology — Sheng Sheng Biology is a biotechnology company that provides medical research and experimental development services.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Germany

Portfolio highlights

ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

Minova Pharma — Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains.
Null Hypothesis — Null Hypothesis is an AI medical SaaS company that focuses on the development of intelligent medical products using AIGC.
Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Investment focus

Manufacturing, Software, Internet
Series A, Series B, Series C
China, India, United States

Portfolio highlights

Darma — DARMA - Digital Healt
Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
Shouxing Technology — AheadForm is pioneering the development of realistic humanoid robots designed to revolutionize human-robot interaction. Our current focus is on creating sophisticated humanoid robot heads that can express emotions, perceive their environment, and interact seamlessly with humans. By combining cutting-edge AI and advanced robotics, we aim to bring life to machines and transform the way humans engage with technology.

Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Series B
China

Portfolio highlights

Errui Xinyue — Errui Xinyue is a developer of early diagnosis technology and products for neurodegenerative diseases. It focuses on the research and use of exosome-related technologies and is committed to progressing the advancement of life and health through technological innovation.
Maybio Matrix — Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Angel, Series B
China

Portfolio highlights

MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
Jianxin Jiaren — Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Angel
China

Portfolio highlights

Immorna — Immorna specializes in the production of RNA-based therapeutics.
ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.

TAIKUN FUND is a centralized investment vehicle designed to pool various sizes and types of capital.

Investment focus

Health Care, Medical, Pharmaceutical
Series A, Series B, Seed
China

Portfolio highlights

Curegene — Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms.
QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
Spruce — Spruce offers quality, objective medical imaging evaluation services for clinical research, aiding medical institutions, biopharmaceutical companies, and medical device companies in drug development, product launch, and treatment effect evaluation.

Longpan Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Series B
China, Cayman Islands

Portfolio highlights

SaiDeDikang — SaiDeDikang is a company focusing on wound management solutions
Senmiao Bio — Beijing Yufan Biopharma is a chemical drug developer specializing in research and development of cancer immunotherapy and small molecule modulators for autoimmune diseases. The company is committed to advancing innovative therapies that address unmet medical needs, with a particular focus on developing next-generation treatments for cancer andimmune-related disorders.
Heyuan Medical Devices — Heyuan Medical Devices serves as an enterprise service provider, offering specialized medical equipment and support solutions tailored to the needs of healthcare institutions and organizations

Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。

Investment focus

Health Care, Biotechnology, Medical
Series A, Seed, Series B
China, United States, Canada

Portfolio highlights

Libo Biotech — Libo Biotech is a cutting-edge biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics that specifically target RNA.
Huarui Shuxin — Huarui Shuxin develops high-performance and high-reliability domestic RAID control cards in the field of core storage hardware.
Suzhou Ribo Life Science — Established in 2007, Suzhou Ribo Life Science Co. Ltd. is devoted to the advanced oligonucleotide therapeutics in China including siRNA, antisense and aptamer drugs based on proprietary intellectual properties.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Manufacturing, Software, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Soundbridge AI — Soundbridge AI specializes in developing cutting-edge, AI-powered speech rehabilitation solutions designed to assist individuals with speech impairments in improving communication skills through personalized, adaptive therapy.
Xuanchuang Robotics — Xuanchuang Robotics is a leading provider of cutting-edge intelligent operations and maintenance solutions, specializing in advanced robotics technologies.
West Lake Intelligent Vision — West Lake Intelligent Vision is a developer of artificial intelligence and computational imaging fusion technology.

Insight Capital is a venture capital firm focused on early-stage investment.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
China

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.

Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing，Shanghai and Hefei.

Investment focus

Manufacturing, Semiconductor, Health Care
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

PaXini Tech — All Scenario Application—Haptic Digitization and Tactile Technology
Ganwei Technology — Wuhan Ganwei Technology is a manufacturer of gas instruments and meters. Its main products include short optical path gas pools, online ultraviolet gas analyzers, gas sensors, oil and gas infrared spectroscopy logging tools, and high-precision automatic gas distribution instruments, etc., which are mainly used in environmental protection,Petrochemical and other fields.
Changzhou Fuxing Mechanical and Electrical Co. — Changzhou Fuxing Mechanical and Electrical Co. manufactures servo, brushless DC, and hybrid stepper motors.

Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.

Investment focus

Health Care, Software, Information Technology
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

UCaize — UCaize is a biopharmaceutical company that researches and develops novel medications for the treatment of blood cancers.
Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.